HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inger K Damon Selected Research

Mpox (monkeypox)

7/2020IMVAMUNE® and ACAM2000® Provide Different Protection against Disease When Administered Postexposure in an Intranasal Monkeypox Challenge Prairie Dog Model.
1/2014Human monkeypox.
1/2012Elucidating the role of the complement control protein in monkeypox pathogenicity.
10/2010Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNA.
4/2009Monkeypox or varicella? Lessons from a rash outbreak investigation in the Republic of the Congo.
10/2007Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection.
4/2007Monkeypox zoonotic associations: insights from laboratory evaluation of animals associated with the multi-state US outbreak.
7/2006Detection of monkeypox virus with real-time PCR assays.
5/2006Monkeypox outbreak diagnostics and implications for vaccine protective effect.
7/2005characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Inger K Damon Research Topics

Disease

26Smallpox (Variola)
04/2022 - 06/2004
18Infections
02/2022 - 03/2004
12Mpox (monkeypox)
07/2020 - 08/2003
7Exanthema (Rash)
07/2020 - 07/2005
7Vaccinia
11/2012 - 08/2003
6Poxviridae Infections
04/2022 - 02/2005
2Ebola Hemorrhagic Fever
02/2022 - 01/2021
2Hypersensitivity (Allergy)
01/2021 - 02/2015
2Weight Loss (Weight Reduction)
07/2020 - 01/2011
2Neoplasms (Cancer)
12/2018 - 06/2007
2Cowpox
01/2011 - 08/2003
2Disease Progression
05/2010 - 01/2010
2Contagious Ecthyma
08/2007 - 06/2007
2Pneumonia (Pneumonitis)
02/2005 - 06/2004
1Anaphylaxis (Anaphylactic Shock)
01/2021
1Vesicular Stomatitis
01/2021
1Eczema
02/2015
1Atopic Dermatitis (Atopic Eczema)
02/2015
1DiGeorge Syndrome (Syndrome, DiGeorge)
02/2015
1HIV Infections (HIV Infection)
02/2015
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
02/2015
1Viremia
01/2015
1Cadaver (Cadavers)
02/2014
1Rabies (Hydrophobia)
01/2012
1Virus Diseases (Viral Diseases)
01/2012
1Infectious Ectromelia
01/2012
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2011
1Communicable Diseases (Infectious Diseases)
01/2011
1Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)
01/2009
1Asymptomatic Infections
10/2007
1Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2007
1Lymphoma (Lymphomas)
06/2007
1Fever (Fevers)
04/2005
1Back Pain (Backache)
04/2005
1Headache (Headaches)
04/2005
1Myalgia
04/2005
1Pruritus (Itching)
04/2005
1Abdominal Pain (Pain, Abdominal)
04/2005
1Pain (Aches)
04/2005
1Fatigue
04/2005
1Arthralgia (Joint Pain)
04/2005
1Encephalitis (Encephalitis, Rasmussen)
11/2004

Drug/Important Bio-Agent (IBA)

22VaccinesIBA
04/2022 - 03/2004
8Smallpox Vaccine (Vaccine, Smallpox)FDA Link
12/2015 - 04/2005
7Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2004
6Antiviral Agents (Antivirals)IBA
04/2022 - 02/2005
5tecovirimatIBA
04/2022 - 03/2009
5Viral DNAIBA
07/2020 - 09/2011
5DNA (Deoxyribonucleic Acid)IBA
12/2013 - 08/2003
5Immunoglobulin M (IgM)IBA
10/2011 - 11/2004
4Immunoglobulin G (IgG)IBA
10/2011 - 07/2005
3ACAM2000IBA
12/2015 - 07/2013
3AntibodiesIBA
01/2012 - 01/2011
2Glycoproteins (Glycoprotein)IBA
01/2021 - 01/2012
2Cidofovir (Vistide)FDA Link
09/2014 - 06/2007
2brincidofovirIBA
09/2014 - 11/2012
2AntigensIBA
01/2013 - 05/2007
2Complement System Proteins (Complement)IBA
01/2012 - 09/2005
2Phosphotransferases (Kinase)IBA
01/2011 - 02/2005
2Indicators and Reagents (Reagents)IBA
10/2010 - 07/2005
2Virulence Factors (Pathogenicity Factors)IBA
05/2010 - 01/2010
2Epidermal Growth Factor (EGF)IBA
02/2005 - 06/2004
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2005 - 06/2004
1Ebola VaccinesIBA
02/2022
1Human Serum AlbuminFDA LinkGeneric
01/2021
1Neutralizing AntibodiesIBA
07/2020
1CytokinesIBA
01/2020
1Tyrosine Kinase InhibitorsIBA
12/2018
1smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordicIBA
02/2015
1Aventis Pasteur smallpox vaccineIBA
02/2015
1LipidsIBA
09/2014
1NucleotidesIBA
09/2014
1Organophosphonates (Phosphonates)IBA
09/2014
1Pharmaceutical PreparationsIBA
12/2013
1Secretory Immunoglobulin A (SIgA)IBA
12/2013
1Immunoglobulins (Immunoglobulin)IBA
11/2012
1Synthetic Vaccines (Recombinant Vaccines)IBA
01/2012
1Rabies Vaccines (Rabies Vaccine)FDA Link
01/2012
1InterferonsIBA
01/2012
1Biological ProductsIBA
01/2012
1Imatinib Mesylate (Gleevec)FDA Link
01/2011
1src-Family KinasesIBA
01/2011
1Interferon Type IIBA
05/2010
1Carrier Proteins (Binding Protein)IBA
05/2010
1Green Fluorescent ProteinsIBA
06/2008
1Biomarkers (Surrogate Marker)IBA
10/2007
1Imiquimod (Aldara)FDA LinkGeneric
06/2007
1ProteomeIBA
05/2007
1Immunodominant EpitopesIBA
05/2007
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
07/2006
1EnzymesIBA
07/2005
1ImmunosorbentsIBA
07/2005
1Investigational DrugsIBA
04/2005
1Tyrosine (L-Tyrosine)FDA Link
02/2005
1Canertinib (CI 1033)IBA
02/2005

Therapy/Procedure

9Therapeutics
01/2014 - 06/2007
1Transplantation
02/2015
1Contraindications
02/2015
1Debridement
06/2007
1Drug Therapy (Chemotherapy)
02/2005